(Circulation. 1996;93:2043-2051.)
© 1996 American Heart Association, Inc.
Articles |
From the Heart Institute, Good Samaritan Hospital, and Department of Medicine, Section of Cardiology, University of Southern California, Los Angeles.
Correspondence to Peter Whittaker, PhD, Heart Institute, Good Samaritan Hospital, 1225 Wilshire Blvd, Los Angeles, CA 90017.
Background Although adenosine has been proposed to be a cardioprotective agent, direct examination of such protection is confounded by its short half-life and hemodynamic effects. We attempted to avoid these problems by injecting adenosine directly into cardiac muscle.
Methods and Results We gave four adenosine injections (each 0.15 mL, 5 mg·mL-1 saline) into the left ventricular wall of rat hearts before a 60-minute occlusion. Although infarcts were smaller in adenosine-treated hearts (29±6%) than in controls (52±5%; P<.05), injection of saline also reduced infarct size (29±7%). Infarcts in hearts subjected to needle insertion but no fluid injection differed neither from control nor from fluid-treated hearts (38±4%). Adenosine reduced ectopic beats and the incidence of ventricular tachycardia during occlusion. In contrast, saline injection prolonged the duration of arrhythmias. To examine the spatial relationship between protection and the injection site, we gave 18 saline injections (each 0.15 mL) into canine myocardium before a 60-minute occlusion. Infarcts were smaller in saline-treated hearts than in controls (P<.01). Because infarcts in four hearts occupied <3% of the risk region, we concluded that fluid injection did not itself cause appreciable necrosis and speculated that muscle was protected in the vicinity of the injection site. Previous work indicated that muscle can be protected by stretch. We examined this hypothesis by adding gadolinium chloride (a stretch-activated channel blocker) to the saline (0.008 g·mL-1) injection in rat hearts. We again found small infarcts after saline injection (26±5%); however, gadolinium blocked protection (50±7%; P<.03).
Conclusions Although we were only partially successful in documenting adenosine-mediated cardioprotection, we found evidence for myocyte protection via a stretch-activated mechanism.
Key Words: adenosine arrhythmia gadolinium myocardial infarction signal transduction
This article has been cited by other articles:
![]() |
D. A. Liem, P. D. Verdouw, H. Ploeg, S. Kazim, and D. J. Duncker Sites of action of adenosine in interorgan preconditioning of the heart Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H29 - H37. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Loh, T. R. Rebbeck, P. D. Mahoney, D. DeNofrio, J. L. Swain, and E. W. Holmes Common Variant in AMPD1 Gene Predicts Improved Clinical Outcome in Patients With Heart Failure Circulation, March 23, 1999; 99(11): 1422 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gysembergh, H. Margonari, J. Loufoua, A. Ovize, X. Andre-Fouet, Y. Minaire, and M. Ovize Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H955 - H964. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Przyklenk, K. Hata, and R. A. Kloner Is Calcium a Mediator of Infarct Size Reduction With Preconditioning in Canine Myocardium? Circulation, August 19, 1997; 96(4): 1305 - 1312. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |